IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pivotal bioVenture Partners Investment Advisor LLC

Q2 2025 Holdings

Filed 2025-08-13 | 12 holdings | $161.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Oculis Holding AG(OCS)ORDINARY SHARESH5870P102$44.7M2,300,77427.7%
Vaxcyte Inc(PCVX)COM92243G108$42.4M1,305,12526.3%
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$29.7M2,120,50818.4%
Inozyme Pharma IncCOM45790W108$18.0M4,494,85111.1%
Zenas Biopharma Inc(ZBIO)COM98937L105$7.5M779,0454.7%
Trevi Therapeutics Inc(TRVI)COM89532M101$6.3M1,146,1103.9%
Vigil Neuroscience Inc(VIGL)COM92673K108$4.5M560,5952.8%
Recursion Pharmaceuticals in(RXRX)CL A75629V104$3.0M595,5181.9%
Bioage Labs Inc(BIOA)COM09077V100$2.7M653,3741.7%
IO Biotech Inc(IOBT)COM449778109$1.2M864,1970.7%
Rallybio CorpCOM75120L100$812.8K2,404,6440.5%
Bolt Biotherapeutics Inc(BOLT)COM NEW097702203$545.7K94,5730.3%